1st INNOLABS Open Call

INNOLABSINNOLABS 1st Open Call for innovative projects in personalized healthcare will be open from the 15th of June until the 30th of September 2017. Up to 25 best ideas from SMEs will be selected to enrol into an Acceleration Programme where each team will obtain support worth up to 50,000€ (equity-free) per project, distributed as follows:
  • 30,000€ direct cash funding.
  • Up to 10,000€ as innovation vouchers to be spent in services provided by external providers validated by Consortium.
  • Up to 10.000€ in additional services provided by consortium partners based on SMEs needs.

Further, up to 25 finalist projects will be selected and receive up to 10,000€ in innovation services per project; this includes:

  • Up to 5,500€ as innovation vouchers to be spent in services provided by external providers validated by Consortium. Up to 4.500€ in additional services provided by consortium partners based on SMEs needs.

The Acceleration Programme will start in December 2017, and during 9 months INNOLABS will provide financial support and offer expert knowledge.

Furthermore a 3 months Fast Lane Programme will be offered to 5 teams of the Open Call.

The INNOLABS acceleration program is non-residential; all collaboration with teams will be done remotely.

The 25 best projects in the ranking are named 'awarded'; the 25 runner ups (position 26-50) in the ranking are named 'finalists'.

The first Open Call, is open to smart health solutions based on combination of ICT, BIO, Health and Medicine sectors. Proposed solutions should solve or meet the needs of ageing populations in rural and urban areas.

For this first INNOLABS Open Call seeks proposals to address at least one of the following proposed challenges:

1. ICT and health - The challenge is to help ageing populations remain independent and active in their communities (especially rural and remote ones) with ICT-based assistive solutions. These solutions should be accessible to consumers (the silver economy) and institutional health care providers and promote participation of stakeholders in the care continuum. They also need to be interoperable and secure whether the solution is an mHealth or eHealth.

2. Biotech and health - As people age they become more susceptible to chronic diseases and co-morbidities (e.g. cancer and diabetes). The challenge is to use biotechnology to support an approach to care that is predictive, preventative and personalised. This encompasses diagnosis, prognosis, treatment options. In practical terms the benefits range from early detection of disease conditions, better informed and personalised clinical decisions in diagnosis and treatment and empowered patients with effective shared care plans.

3. Solutions generated by end-users need identification - We are seeing a shift from industry-driven products to ones that are more demand-driven by the end-user. This might involve the co-design of solutions as well as their testing. With this challenge, we are seeking solutions that builds on an original idea generated from (i) someone working within or (ii) a patient(s) treated by - a service along the health and social care continuum. In particular, we are interested in products and processes that are more affordable and less invasive.

Applicants need to engage one or more of these specific challenges in order to be an eligible candidate.

Application requirements

The requirements to participate in the INNOLABS Open Call process are as follows:
  • Teams will have to address the challenges of the Open Call.
  • Teams must be composed of at least 2 legal entities from an EU or associate country
  • Teams must be led by an SME.
  • The proposed innovation project must include cross over between sectors namely ITC, BIO, Medical and target addressing listed Health challenges in the INNOLABS first open call.
  • Extra points in the evaluation, if team represents legal entities from 2 different countries
  • Extra points in the evaluation, if the team is composed by at least 2 SMEs.
  • Extra points if the Project Leader has been awarded the EC Seal of Excellence in the 12 months preceding call launch.

In order to help participants to search for partners, a matchmaking portal will be available on the INNOLABS web page.

For further information and application forms, please visit:
https://www.innolabs.io/open-call.html

About INNOLABS
INNOLABS is looking for new cross-sectorial health solutions for personalized health. To achieve this purpose, INNOLABS will invest 3.75 Million EUR with the aim to foster collaboration, transfer of knowledge and opportunities among European SMEs for different countries and sectors in order to develop, improve and deliver disruptive technologies for personalized health.

More specifically, INNOLABS aims to support projects based on the combination of ICT, BIO, Health and Medical sectors for the benefit of ageing populations and rural areas that incorporate mHealth technologies.

INNOLABS main objective is that SMEs with mutually reinforcing competencies can be supported in view of creating new industrial value chains that foster the development of emerging industries in Europe. To this end, INNOLABS is specifically carrying on a large number of activities:

  • 2 Contest Idea Events and associated Open Calls for team profile matching and competition. Best ideas will be funded and a specific 3-months fast innovation pipeline provided as opt in, on top of the normal acceleration program.
  • 3 Hacktathons and 3 Bootcamps with SME patronage competitions. Direct prizes for best ideas.
  • Focussed lectures, workshops, webinars and different event formats used and employed for achieving objectives.
  • Innovation vouchers, prizes and other measures for direct support.

Starting on the 1st of January 2017, the project has a duration of 2.5 years and is supported by Horizon 2020, the EU Framework Program for Research and Innovation.

Most Popular Now

Novartis and Microsoft Announce Collabor…

Novartis announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft as its strategic AI and data-science partner for this effort. The...

Guerbet and IBM Watson Health Announce a…

Guerbet, a global specialist in contrast agents and solutions for diagnostic and interventional medical imaging, announced that it has signed a new agreement with IBM Watson Health to co-develop and...

Bayer Inks Deals with Eleven Startups un…

Bayer announced today that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term collaborations...

Orion Health Delivers the First Health I…

The first Health Information Exchange (HIE) in the Middle East, Malaffi, went live at the end of July just six months after contracts were signed between the project company, Abu...

Joined Up Health and Care 2019 to Explor…

Professionals from across the country will come together to seek real answers on how to deliver closely integrated services, as the Joined Up Health and Care conference returns for its...

IMS MAXIMS Wins Healthcare Innovation Aw…

Health technology specialist IMS MAXIMS has been recognised for its innovative work in the UK and Irish healthcare market in the 2019 CV Business Innovator Awards. The company has been...

Almirall Takes a Leap into Dermatology D…

Almirall, S.A. (ALM) has launched its first call for innovation to start-ups focused on dermatology digital health. This initiative is the first step in the creation of an accelerator programme...

Health Tech Marketing and PR Agency Incr…

Highland Marketing, a full service agency for health techmarketing, PR and communications, has appointed Tia Dissanayake to a new account executive role,in which she will support the team withher life...

Brain-Computer Interfaces without the Me…

It sounds like science fiction: controlling electronic devices with brain waves. But researchers have developed a new type of electroencephalogram (EEG) electrode that can do just that, without the sticky...

Up-Close and Personal with Neuronal Netw…

How our brain cells, or neurons, use electrical signals to communicate and coordinate for higher brain function is one of the biggest questions in all of science. For decades, researchers...